文献速递新生儿儿童呼吸

先天性膈疝婴儿气管软化与气管扩张:FETO与非FETO多中心回顾队列

Tracheomalacia and tracheomegaly in infants and children with congenital diaphragmatic hernia managed with and without fetoscopic endoluminal tracheal occlusion (FETO): a multicentre, retrospective cohort study.
PubMed 文献 · Lancet Child Adolesc Health · 2024-06-21

这项多中心回顾性队列纳入505例先天性膈疝活产婴儿,比较接受与未接受胎儿镜下气管内球囊封堵(FETO)者。

要点

  • 有症状气管软化13例(5%),其中10例(77%)缓解。

核心结论

  • FETO与气管直径增大及气管软化概率增加相关,但有症状气管软化通常随时间缓解。
  • 球囊封堵逆转距分娩不足24小时时,金属球囊部件滞留体内风险更高。
  • 随访期间未报告滞留体内金属部件的不良反应,仍需更长期随访。

研究设计与样本

  • 多中心回顾性队列研究,纳入2002年4月5日至2021年6月2日四中心收治的先天性膈疝活产婴儿505例,其中287例接受FETO、218例未接受。

主要发现

  • 205例有胸腹X线的婴儿中,75例(37%)出生时体内可见金属部件,其中胃肠道60例(80%)、肺15例(20%);封堵逆转距分娩不足24小时时金属部件更可能位于肺。

关键数值与推荐

  • 校正模型纳入疝侧别、观察与预期肺头比、出生孕周。
  • 采用改良Poisson回归计算粗和校正风险比及95%CI,线性回归计算粗和校正均差及95%CI。

临床怎么用

  • 对FETO后先天性膈疝婴儿应关注气管软化相关症状,并告知多数有症状者随时间缓解。
  • 封堵逆转距分娩不足24小时者需警惕金属球囊部件滞留肺内,出生X线可协助定位。
  • 对体内滞留金属部件者需长期随访,目前随访期内未报告不良反应。

局限性

  • 为回顾性队列,气管软化基于病历记录,可能存在报告偏倚。
  • 仅四中心数据,结论外推需谨慎。
  • 随访时间有限,不足以评估远期气管问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Temporary fetoscopic endoluminal tracheal occlusion (FETO) promotes lung growth and increases survival in selected fetuses with congenital diaphragmatic hernia (CDH). FETO is performed percutaneously by inserting into the trachea a balloon designed for vascular occlusion. However, reports on the potential postnatal side-effects of the balloon are scarce. This study aimed to evaluate the prevalence of tracheomalacia in infants with CDH managed with and without FETO and other consequences related to the use of the balloon. METHODS: In this multicentre, retrospective cohort study, we included infants who were live born with CDH, either with FETO or without, who were managed postnatally at four centres (UZ Leuven, Leuven, Belgium; Antoine Béclère, Clamart, France; BCNatal, Barcelona, Spain; and HCor-Heart Hospital, São Paulo, Brazil) between April 5, 2002, and June 2, 2021. We primarily assessed the prevalence of all (symptomatic and asymptomatic) tracheomalacia as reported in medical records among infants with and without FETO. Secondarily we assessed the prevalence of symptomatic tracheomalacia and its resolution as reported in medical records, and compared tracheal diameters as measured on postnatal x-rays. Crude and adjusted risk ratios (aRRs) and 95% CIs were calculated via modified Poisson regression models with robust error variances for potential association between FETO and tracheomalacia. Variables included in the adjusted model were the side of the hernia, observed-to-expected lung-to-head ratio, and gestational age at birth. Crude and adjusted mean differences and 95% CIs were calculated via linear regression models to assess the presence and magnitude of association between FETO and tracheal diameters. In infants who had undergone FETO we also assessed the localisation of balloon remnants on x-rays, and the methods used for reversal of occlusion and potential complications associated with balloon remnants as documented in clinical records. Finally we investigated whether the presence of balloon remnants was influenced by the interval between balloon removal and delivery. FINDINGS: 505 neonates were included in the study, of whom 287 had undergone FETO and 218 had not. Tracheomalacia was reported in 18 (6%) infants who had undergone FETO and in three (1%) who had not (aRR 6·17 [95% CI 1·83-20·75]; p=0·0030). Tracheomalacia was first reported in the FETO group at a median of 5·0 months (IQR 0·8-13·0). Symptomatic tracheomalacia was reported in 13 (5%) infants who had undergone FETO, which resolved in ten (77%) children by 55·0 months (IQR 14·0-83·0). On average, infants who had undergone FETO had a 31·3% wider trachea (with FETO tracheal diameter 7·43 mm [SD 1·24], without FETO tracheal diameter 5·10 mm [SD 0·84]; crude mean difference 2·32 [95% CI 2·11-2·54]; p<0·0001; adjusted mean difference 2·62 [95% CI 2·35-2·89]; p<0·0001). At birth, the metallic component was visible within the body in 75 (37%) of 205 infants with available thoraco-abdominal x-rays: it was located in the gastrointestinal tract in 60 (80%) and in the lung in 15 (20%). No side-effects were reported for any of the infants during follow-up. The metallic component was more likely to be in the lung than either outside the body or the gastrointestinal tract when the interval between occlusion reversal and birth was less than 24 h. INTERPRETATION: Although FETO was associated with an increased tracheal diameter and an increased probability of tracheomalacia, symptomatic tracheomalacia typically resolved over time. There is a higher risk of retention of metallic balloon components if reversal of the occlusion occurs less than 24 h before delivery. Finally, there were no reported side-effects of the metallic component of the balloon persisting in the body during follow-up. Longer-term follow-up is needed to ensure that no tracheal problems arise later in life. FUNDING: None.

来源:Lancet Child Adolesc Health,查看原文。版权归原作者所有。

引用

  1. Basurto D, Watananirun K, Cordier AG, et al. Tracheomalacia and tracheomegaly in infants and children with congenital diaphragmatic hernia managed with and without fetoscopic endoluminal tracheal occlusion (FETO): a multicentre, retrospective cohort study. Lancet Child Adolesc Health. 2024. PMID: 38914091. doi:10.1016/S2352-4642(24)00109-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。